View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
December 22, 2021updated 11 Mar 2022 6:30am

FDA grants marketing approval to Philips’ filter removal device

Philips CavaClear laser sheath removes tissue to enable the detachment of IVC filters from the wall using laser energy.

The US Food and Drug Administration (FDA) has granted marketing authorisation to Philips’ Inferior Vena Cava (IVC) filter removal device, CavaClear Laser Sheath.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

CavaClear is claimed to be the first laser-based device that can be used to remove IVC filters.

It is designed for patients with an IVC filter inserted to capture blood clots and prevent transmission to the lungs.

IVC filter is a small cage-like device which is frequently used in patients who are at pulmonary embolism risk when treatment with blood thinners is ineffective.

Although certain IVC filters are left permanently, the FDA issued a safety communication to remove the devices as quickly as blood clots are no longer at risk for the patient due to reports of adverse events related to IVC filters.

Using ultraviolet laser energy, Philips CavaClear laser sheath removes tissue to enable the detachment of IVC filters from the IVC wall to eliminate a small amount tissue.

It can be used in conjunction with other snare devices in order to assist in IVC filter removal.

The US FDA has evaluated the device’s efficacy and safety in a real-world evidence, retrospective clinical study.

In the study, the laser assisted IVC filter removal was evaluated in 265 participants at seven centres and showed 96% procedural technical success rate.

FDA Center for Devices and Radiological Health Cardiovascular Devices Office director Bram Zuckerman said: “To date, there have been limited options for the successful removal of chronically embedded IVC filters, as they can be difficult to retrieve due to potential complications associated with the complex procedure.

“Today’s action by the FDA will provide physicians with an important tool for the safe removal of IVC filters and potentially help reduce complications for patients.

“It also demonstrates FDA’s commitment to leveraging real world evidence where appropriate to evaluate device safety and effectiveness.”

The regulator stated that the Philips CavaClear Laser Sheath is not recommended when a blood clot is formed within the filter or in the veins surrounding.

It also noted that the device is not designed to remove VenaTech IVC filters and Bird’s Nest IVC filter.

In July this year, the US FDA granted breakthrough device designation to the laser assisted IVC filter removal device.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network